The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 164:1206-1213, August 2007
doi: 10.1176/appi.ajp.2007.06071172
© 2007 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Suri, R.
* Articles by Mintz, J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Suri, R.
* Articles by Mintz, J.
Related Collections
* Depression
* Antidepressants

Effects of Antenatal Depression and Antidepressant Treatment on Gestational Age at Birth and Risk of Preterm Birth

Rita Suri, M.D., Lori Altshuler, M.D., Gerhard Hellemann, Ph.D., Vivien K. Burt, M.D., Ph.D., Ana Aquino, B.S., and Jim Mintz, Ph.D.

OBJECTIVE: The authors evaluated the effects of prenatal antidepressant exposure and maternal depression on infant gestational age at birth and risk of preterm birth. METHOD: Ninety women were followed in a prospective, naturalistic design through pregnancy with monthly assessments of symptoms of depression and anxiety using the Structured Clinical Interview for DSM-IV mood module for depression, the Hamilton Depression Rating Scale, the Beck Depression Inventory, and the Perceived Stress Scale. Participants included 49 women with major depressive disorder who were treated with antidepressants during pregnancy (group 1), 22 women with major depressive disorder who were either not treated with antidepressants or had limited exposure to them during pregnancy (group 2), and 19 healthy comparison subjects (group 3). The primary outcome variables were the infants’ gestational age at birth, birth weight, 1- and 5-minute Apgar scores, and admission to the special care nursery. RESULTS: Groups 1, 2, and 3 differed significantly in gestational age at birth (38.5 weeks, 39.4 weeks, 39.7 weeks, respectively), rates of preterm birth (14.3%, 0%, 5.3%, respectively), and rates of admission to the special care nursery (21%, 9%, 0%, respectively). Birth weight and Apgar scores did not differ significantly between groups. Mild to moderate depression during pregnancy did not affect outcome measures. CONCLUSIONS: Prenatal antidepressant use was associated with lower gestational age at birth and an increased risk of preterm birth. Presence of depressive symptoms was not associated with this risk. These results suggest that medication status, rather than depression, is a predictor of gestational age at birth.




This article has been cited by other articles:


Home page
J PsychopharmacolHome page
C. Moret, M. Isaac, and M. Briley
Review: Problems associated with long-term treatment with selective serotonin reuptake inhibitors
J Psychopharmacol, November 1, 2009; 23(8): 967 - 974.
[Abstract] [PDF]


Home page
Am. J. PsychiatryHome page
A. C. URATO
Antidepressant Use and Preterm Birth
Am J Psychiatry, October 1, 2009; 166(10): 1189 - 1189.
[Full Text] [PDF]


Home page
FocusHome page
K. L. Wisner, D. K.Y. Sit, B. H. Hanusa, E. L. Moses-Kolko, D. L. Bogen, D. F. Hunker, J. M. Perel, S. Jones-Ivy, L. M. Bodnar, and L. T. Singer
Major Depression and Antidepressant Treatment: Impact on Pregnancy and Neonatal Outcomes
Focus, July 1, 2009; 7(3): 374 - 384.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
K. L. Wisner, D. K.Y. Sit, B. H. Hanusa, E. L. Moses-Kolko, D. L. Bogen, D. F. Hunker, J. M. Perel, S. Jones-Ivy, L. M. Bodnar, and L. T. Singer
Major Depression and Antidepressant Treatment: Impact on Pregnancy and Neonatal Outcomes
Am J Psychiatry, May 1, 2009; 166(5): 557 - 566.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
I. Anderson, I. Ferrier, R. Baldwin, P. Cowen, L Howard, G Lewis, K Matthews, R. McAllister-Williams, R. Peveler, J Scott, et al.
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines
J Psychopharmacol, June 1, 2008; 22(4): 343 - 396.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. W. Rich-Edwards, A. P. Mohllajee, K. Kleinman, M. R. Hacker, J. Majzoub, R. J. Wright, and M. W. Gillman
Elevated Midpregnancy Corticotropin-Releasing Hormone Is Associated with Prenatal, But Not Postpartum, Maternal Depression
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1946 - 1951.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
T.-H. LAN, B.-J. WU, H.-J. CHIU, T.-M. HU, and Y.-C. TUAN
Depression Status as a Confounder in the Effects of Antidepressants on the Gestation Age
Am J Psychiatry, March 1, 2008; 165(3): 399 - 400.
[Full Text] [PDF]


Home page
JWatch PsychiatryHome page
Psychiatric Medications, Psychiatric Disorders, and Pregnancy: New Data
Journal Watch Psychiatry, October 1, 2007; 2007(1001): 1 - 1.
[Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 2007 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org